# OnCo record codebreak-200 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/codebreak-200/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "codebreak-200", "NCT04303780" ;
  schema:name "CodeBreaK 200"@en ;
  schema:description "The first randomised trial of a KRAS drug: better than chemotherapy on progression, not on survival."@en ;
  schema:url <https://onco.cc/trials/codebreak-200/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04303780> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2020-06-04" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/kras-g12c-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kras-inhibitors/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:drugs <https://onco.cc/drugs/sotorasib/> ;
  onco:companies <https://onco.cc/companies/amgen/> ;
  onco:people <https://onco.cc/people/ferdinandos-skoulidis/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-codebreak-200-lancet-2023/> .